APA (7th ed.) Citation

Alekseev, S. M., Kaplanov, K. D., Ivanov, R. A., & Chernyaeva, E. V. (2015). CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®. QUASAR, LLC.

Chicago Style (17th ed.) Citation

Alekseev, S. M., K. D. Kaplanov, R. A. Ivanov, and E. V. Chernyaeva. CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®. QUASAR, LLC, 2015.

MLA (9th ed.) Citation

Alekseev, S. M., et al. CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®. QUASAR, LLC, 2015.